Lidoflazine: double-blind trial of a new coronary vasodilator in angina pectoris.
D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy*; D000818:Animals; D002986:Clinical Trials as Topic; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004562:Electrocardiography; D006801:Humans; D008013:Lidoflazine / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D005996:Nitroglycerin / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use*; D010919:Placebos; D013223:Statistics as Topic; D013997:Time Factors; D014665:Vasodilator Agents / Q000627:therapeutic use*
D004071:Digitalis Glycosides; D010879:Piperazines; D010919:Placebos; D014665:Vasodilator Agents; D005996:Nitroglycerin; D008013:Lidoflazine